Frontlight ResearchEarly access
Triple-negative breast cancer trials in Russia
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Where
- Arkhangelsk, Barnaul, Chelyabinsk, Izhevsk, Kaluga, Kazan', Krasnodar, Moscow, Nizhny Novgorod, Novosibirsk, Obninsk, Omsk, Rostov-on-Don, Ryazan, Saint Petersburg, Saransk, Severodvinsk, Tambov, Ufa, Volgograd, Yaroslavl, Yekaterinburg
- Age
- 18 years to 74 years
- People
- 124 worldwide
- Run by
- Biocad
See details and how to joinNCT07108309